Patients With HR-Positive Breast Cancer Can Safely Use ART

New data from the POSITIVE trial show the efficacy and short-term safety of fertility preservation and assisted reproductive technology (ART) for young women with HR-positive breast cancer.

Related Keywords

Monterrey ,Nuevo Leóx ,Mexico ,Seoul ,Soult Ukpyolsi ,South Korea ,Dallas ,Texas ,United States ,Republic Of Korea ,Hatema Azim Jr ,Hee Jeong Kim ,Carlos Arteaga ,School Of Medicine ,Simmons Comprehensive Cancer Center ,Ut Southwestern Medical Center ,Monterrey Institute Of Technology ,Asan Medical Center ,Division Of Breast Surgery ,Breast Cancer Center ,Monterrey Institute ,San Antonio Breast Cancer Symposium ,Medscape Medical News ,Breast Cancer ,Breast Surgery ,Medical Center ,Alignant Breast Neoplasm ,Breast Carcinoma ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,Breast ,Mammary Gland ,Assisted Reproductive Technology Reproduction ,Assisted Reproductive Technologies ,Ssisted Reproductive Technologies Art ,Biologic Therapy ,Iologics ,Female Infertility ,Reproductive Technology ,Pregnancy ,Pregnant ,Fertility ,